Method of treating anemia by administering IL-1ra

Drug – bio-affecting and body treating compositions – Lymphokine

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S002600, C514S008100, C514S012200

Reexamination Certificate

active

07087224

ABSTRACT:
The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.

REFERENCES:
patent: 5075222 (1991-12-01), Hannum et al.
patent: 0 393 438 (1990-04-01), None
patent: 0 422 339 (1998-01-01), None
patent: 0 855 404 (1998-07-01), None
patent: 0 148 605 (1998-12-01), None
patent: WO 96/09323 (1996-03-01), None
patent: WO 97/28828 (1997-08-01), None
patent: WO 98/01555 (1998-01-01), None
patent: WO 00/24893 (2000-05-01), None
patent: WO 00/26209 (2000-05-01), None
patent: WO 00/59530 (2000-10-01), None
patent: WO 02/096461 (2002-12-01), None
Thomas et al. Agents and Actions, (Sep. 1991) 34 (1-2), pp. 187-190.
Carter et al. (1990), “Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein,”Nature344:633-638.
Means et al. (1999), “Commentary: An anemia of chronic disease, after all?, ”J. Investigative Medicine47(5): 203.
Peeters et all. (1996), “Course and Characteristics of Anaemia in Patients with Rheumatoid Arthritis of Recent Onsent,”Ann. Rheum. Dis., 55: 162-68.
Pincus et al. (1990), “Multicenter Study of Recombinant Human Erythropoietin in Correction of Anemia in Rheumatoid Arthritis,”Am. J. Med. 89:161.
Tanaka et al. (1999), “Autologous blood transfusion with recombinant erythropoietin treatment in anaemic patients with rheumatoid arthritis,”Clinical Rheumatology18(4): 293-298.
Voulgari, et al. (1999), “Role of Cytokines in the Pathogenesis of Anemia of Chronic Disease in Rheumatoid Arthritis,”Clin. Immunol. 92:153-160.
Galon et al. (2000), “TNFRSF1A Mutations and Autoinflammatory Syndroms,”Current Opinion in Immunology12: 479-486.
Glennie et al. (2000), “Clinical Trials of Antibody Therapy,”Immunology Today21(8): 403-410.
Lee et al. (1999), “Erythropoietin plus iron supplement prevents significant anemia during concurrent chemo-radiation therapy in patients with locally-advanced inoperable non-small cell lung cancer,”Proceedings of the American Association for Cancer Research Annual Meeting40: 642.
MacDougall et al. (1999), “Pharmacokinetics of Novel Erythropoietin Stimulating Protein Compared with Epoietin Alfa in Dialysis Patients,”J. Am. Society of Nephrology10: 2392-2395.
Means (1999), “Advances in the Anemia of Chronic Disease,”International J. of Hematol. 70(1):7-12.
Faquin et al. (1992), “Effect of Inflammatory Cytokines on Hypoxia-Induced Erythropoietin Production,”Blood79:1987-1994.
Means et al. (1992), “Progress in Understanding the Pathogenesis of the Anemia of Chronic Disease,”Blood80:1639-1647.
Nieken et al. (1995), “Recombinant Human Interleukin-6 Induces a Rapid and Reversible Anemia in Cancer Patients,”Blood86:900-905.
Smith et al. (1992), “Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythropoietin and of interleukin 1 production by marrow macrophages,”Annals of the Rheumatic Diseases51: 753-757.
Sun et al. (1993), “The Influence of Recombinant Human Interleukin-6 on Blood and Immune Parameters in Middle-aged and Old Rhesus Monkeys,”Lymphokine Cytokine Research12:449-455.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of treating anemia by administering IL-1ra does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating anemia by administering IL-1ra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating anemia by administering IL-1ra will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3644687

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.